Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
暂无分享,去创建一个
J. Sakamoto | K. Goto | A. Ohtsu | S. Saji | Toshiaki Watanabe | K. Oba | K. Ishigure | T. Yoshino | Keiji Inoue | D. Manaka | J. Hasegawa | T. Matsui | M. Kotaka | K. Shinozaki | T. Touyama